SCI Financial Statements From 2010 to 2025
| 4119 Stock | TWD 82.90 0.50 0.60% |
Check SCI Pharmtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SCI Pharmtech's main balance sheet or income statement drivers, such as , as well as many indicators such as . SCI financial statements analysis is a perfect complement when working with SCI Pharmtech Valuation or Volatility modules.
SCI |
SCI Pharmtech Company Current Valuation Analysis
SCI Pharmtech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current SCI Pharmtech Current Valuation | 9.19 B |
Most of SCI Pharmtech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SCI Pharmtech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, SCI Pharmtech has a Current Valuation of 9.19 B. This is 36.02% lower than that of the Pharmaceuticals sector and 23.61% higher than that of the Health Care industry. The current valuation for all Taiwan stocks is 44.72% higher than that of the company.
SCI Pharmtech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SCI Pharmtech's current stock value. Our valuation model uses many indicators to compare SCI Pharmtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SCI Pharmtech competition to find correlations between indicators driving SCI Pharmtech's intrinsic value. More Info.SCI Pharmtech is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.13 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for SCI Pharmtech is roughly 7.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SCI Pharmtech's earnings, one of the primary drivers of an investment's value.About SCI Pharmtech Financial Statements
SCI Pharmtech investors use historical fundamental indicators, such as SCI Pharmtech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SCI Pharmtech. Please read more on our technical analysis and fundamental analysis pages.
SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and specialty chemicals in Taiwan. SCI Pharmtech, Inc. was founded in 1987 and is based in Taoyuan City, Taiwan. SCI PHARMTECH operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SCI Stock Analysis
When running SCI Pharmtech's price analysis, check to measure SCI Pharmtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCI Pharmtech is operating at the current time. Most of SCI Pharmtech's value examination focuses on studying past and present price action to predict the probability of SCI Pharmtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCI Pharmtech's price. Additionally, you may evaluate how the addition of SCI Pharmtech to your portfolios can decrease your overall portfolio volatility.